TMUNITY Trademark

Trademark Overview

On Friday, May 12, 2017, a trademark application was filed for TMUNITY with the United States Patent and Trademark Office. The USPTO has given the TMUNITY trademark a serial number of 87447152. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by Tmunity Therapeutics, Inc.. The TMUNITY trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, engineered cells for immunotherapy purposes
tmunity

General Information

Serial Number87447152
Word MarkTMUNITY
Filing DateFriday, May 12, 2017
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6124923
Registration DateTuesday, August 11, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2017

Trademark Statements

Goods and ServicesBiological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, engineered cells for immunotherapy purposes
Pseudo MarkTM UNITY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 17, 2017
Primary Code005
First Use Anywhere DateTuesday, February 25, 2020
First Use In Commerce DateTuesday, February 25, 2020

Trademark Owner History

Party NameTmunity Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameTmunity Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameTmunity Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Wednesday, May 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 16, 2017NEW APPLICATION ENTERED
Friday, May 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 11, 2017ASSIGNED TO EXAMINER
Wednesday, August 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 26, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 16, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, May 16, 2018SOU EXTENSION 1 FILED
Wednesday, May 16, 2018SOU EXTENSION 1 GRANTED
Tuesday, November 19, 2019SOU EXTENSION 4 FILED
Friday, November 16, 2018SOU TEAS EXTENSION RECEIVED
Friday, November 16, 2018SOU EXTENSION 2 FILED
Friday, November 16, 2018SOU EXTENSION 2 GRANTED
Tuesday, November 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019SOU TEAS EXTENSION RECEIVED
Monday, May 20, 2019SOU EXTENSION 3 FILED
Monday, May 20, 2019SOU EXTENSION 3 GRANTED
Wednesday, May 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 19, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019SOU EXTENSION 4 GRANTED
Wednesday, July 8, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, May 19, 2020USE AMENDMENT FILED
Tuesday, June 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, June 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 9, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER

Related Keywords

tmunity treatment therapy cancer preparations engineered products namely cells purposes immunotherapy